It’s not all that unusual for a firm to get a Form 483 following an FDA inspection. Occasionally when the FDA considers the firm’s response
Infant formula is, once again, stirring controversy in the food industry, and it is raising issues of which the entire industry should be aware. It
Just as TAG had predicted, the issues that arose during the infant formula Cronobacter outbreak and supply shortage have continued to bear down on, not
The recent shortages of infant formula and the fallout from prior facility inspections of the manufacturer have most certainly energized Congress to take action that
